<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the expression of epidermal growth factor receptor (EGFR) in hematopoietic cells and investigate its relationship to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Mononuclear cells from 18 MDS patients were used to analyze the expression of EGFR and the apoptotic signals by immunocytochemical technique and TdT-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labelling (TUNEL) <z:chebi fb="0" ids="31624">fluorescein</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Flow cytometry (FCM) sorted CD(34)(+) cells from 15 MDS cases and 6 <z:mpath ids='MPATH_458'>normal</z:mpath> donors were also analyzed for the EGFR expression and apoptotic signals </plain></SENT>
<SENT sid="3" pm="."><plain>Nine <z:mpath ids='MPATH_458'>normal</z:mpath> marrow samples were taken as controls </plain></SENT>
<SENT sid="4" pm="."><plain>EGFR expression and its relationship to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were analysed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: (1) There was a higher EGFR expression rate (38.6 +/- 24.6)% in nucleated cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow than in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (18.1 +/- 14.0)% (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>(2) <z:mpath ids='MPATH_3'>Apoptosis</z:mpath> occurred much more in EGFR negative cells (16.1%) than in EGFR positive cells (1.4%) (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>EGFR expression showed negative correlation with <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (r = -0.701; t(r) = 3.60; P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>(3) In CD(34)(+) cells, EGFR expression rate seemed higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> than that in RA/<z:mp ids='MP_0011356'>RAS</z:mp> (20.6 +/- 27.9 vs 8.9 +/- 11.8%) subgroup (P &gt; 0.05), while <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> subgroup than in RA/<z:mp ids='MP_0011356'>RAS</z:mp> cases (18.2 +/- 12.5 vs 45.2 +/- 20.5%) (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: There is overexpression of EGFR in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases </plain></SENT>
<SENT sid="10" pm="."><plain>And it seems that the overexpressed EGFR represent somewhat the malignant proliferation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and suppress <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through a unknown mechanism </plain></SENT>
</text></document>